Navigation Links
SV Life Sciences Appoints Veteran Diagnostics Professional Dr. Heiner Dreismann as Venture Partner
Date:10/5/2011

BOSTON, SAN FRANCISCO and LONDON, Oct. 5, 2011 /PRNewswire/ --SV Life Sciences ("SVLS") today announced the appointment of Dr. Heiner Dreismann, as Venture Partner. Dr. Dreismann joins SVLS with more than 26 years of experience in the health care industry.

"We are very excited to welcome Dr. Dreismann to SVLS," said Lutz Giebel, SVLS Managing Partner. "Dr. Dreismann will join our biotechnology team and focus on investments in the diagnostics space. We believe favorable market dynamics make this a perfect time to expand our capabilities in this area and Dr. Dreismann's knowledge and expertise will be invaluable assets as we do so."

Dr. Dreismann is highly regarded in the healthcare industry with over 26 years of experience. He serves on the boards of several innovative public and private diagnostic companies. Dreismann completed a successful career at Roche Group from 1985 to 2006 where he held several senior positions including President and CEO of Roche Molecular Systems, Head of Global Business Development at Roche Diagnostics and Member of Roche's Global Diagnostic Executive Committee.

"Joining SVLS is a tremendous opportunity for me to bring my expertise in diagnostics and life sciences to venture capital investing," said Dreismann. "SVLS has a stellar market reputation and I look forward to helping grow the diagnostics vertical in the firm's portfolio."

Dr. Dreismann earned a Master of Science in biology and a Doctor of Philosophy in microbiology/molecular biology from Westfaelische Wilhelms University in Muenster, Germany. He conducted his Post-Doctoral studies in microbial genetics at the Centre d'Etudes Nucleaires de Saclay, France. Dr. Dreismann is an active member of the in vitro diagnostics (IVD) industry community and is regarded as a pioneer in the early adoption of the polymerase chain reaction (PCR) technique.

Dr. Dreismann is a member of SVLS' team of 35 professionals organized according to experience and speci
'/>"/>

SOURCE SV Life Sciences
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
2. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
3. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
4. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
5. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
6. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
7. Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
8. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
9. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
10. Alfacell Corporation to Present at UBS Global Life Sciences Conference
11. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... NEW YORK , Sept. 17, 2014  Levi ... ALXA) in connection with possible claims of breaches of ... Company. To get more information, click here: ... to you. If you own common stock ... information, please contact Eduard Korsinsky, Esq. either ...
(Date:9/17/2014)... Sept. 17, 2014 /PRNewswire-iReach/ -- ChemImage announced ... discussing improvements in the development of imaging ... both normal and diseased tissue that minimizes ... surgical procedures, lowers surgical costs and potentially ... The clinical and scientific ...
(Date:9/17/2014)... 2014 Bronstein, Gewirtz & Grossman, LLC is ... securities of PDL BioPharma, Inc. ("PDL BioPharma" or the ... are advised to contact Peretz Bronstein or ... info@bgandg.com or 212-697-6484. The investigation ... executives violated federal securities laws. On September ...
Breaking Medicine Technology:Patient Outcomes Improve When Molecular Chemical Imaging Technology Is Used to Aid Robotic Surgical Procedures, According to New White Paper 2Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Investigates claims on behalf of Investors of PDL BioPharma, Inc. --PDLI 2
... Feb. 21, 2012 A collaboration between NineSigma and ... advance HIV vaccine research by identifying new approaches to ... provider of innovation services , NineSigma has connected ... and helped it identify two scientists who will receive ...
... #8116 -- Precyse, a leader in health information ... HIMSS 2012 Annual Conference and Exposition that the ... improvements in revenue cycle workflow, coding accuracy, and ... adopting Precyse,s integrated health information management (HIM) and ...
Cached Medicine Technology:IAVI and NineSigma Collaborate to Identify New Approaches to Developing AIDS Vaccines 2IAVI and NineSigma Collaborate to Identify New Approaches to Developing AIDS Vaccines 3IAVI and NineSigma Collaborate to Identify New Approaches to Developing AIDS Vaccines 4Growing List of Providers Accelerate Revenue Cycles, Improve Clinical Documentation Through True Computer-Assisted Coding with Natural Language Comprehension™ 2Growing List of Providers Accelerate Revenue Cycles, Improve Clinical Documentation Through True Computer-Assisted Coding with Natural Language Comprehension™ 3Growing List of Providers Accelerate Revenue Cycles, Improve Clinical Documentation Through True Computer-Assisted Coding with Natural Language Comprehension™ 4
(Date:9/17/2014)... University] As Congress adjourns this month for the ... step over on their way out the chamber door ... Medicare Provider Payment Modernization Act of 2014. In a ... Dr. Eli Adashi recounts what he and other advocates ... The perennial trouble with how Medicare pays doctors will ...
(Date:9/17/2014)... 17, 2014 Wright hip lawsuit ... of metal-on-metal hip replacements continue to grow in ... Court, Northern District of Georgia, Bernstein Liebhard LLP ... by the U.S. Judicial Panel on Multidistrict Litigation ... liability claims have been filed in the proceeding ...
(Date:9/17/2014)... 2014 Boston Children’s Museum and ... monthly concert series, introducing young Museum visitors to ... America’s premier national platform celebrating the stories, talents, ... the young musicians featured will also be showcased ... Museum is fortunate to partner with the wonderful ...
(Date:9/17/2014)... Austin, TX (PRWEB) September 17, 2014 ... the Editor’s Picks by Progressive Grocer, a leading trade ... Pizza was awarded for originality and flavor, among other ... featured as an Editor’s Pick in the September print ... Progressive Grocer website. , The pizza won based on ...
(Date:9/17/2014)... 17, 2014 StartX , a ... companies raising rounds of funding at its Summer Demo ... investors and media, was the first such gathering held ... to the university. The presentations were delivered on an ... StartX-QB3 Labs, a 2,000 square foot life science facility ...
Breaking Medicine News(10 mins):Health News:Failed Medicare payments law remains relevant 2Health News:Failed Medicare payments law remains relevant 3Health News:Wright Hip Lawsuit News: Nearly 400 Filings Reported in Federal Wright Conserve Hip Replacement Litigation, Bernstein Liebhard LLP Reports 2Health News:Wright Hip Lawsuit News: Nearly 400 Filings Reported in Federal Wright Conserve Hip Replacement Litigation, Bernstein Liebhard LLP Reports 3Health News:Boston Children's Museum Partners with From the Top to Offer Monthly Concert Series 2Health News:Boston Children's Museum Partners with From the Top to Offer Monthly Concert Series 3Health News:Smart Flour Foods Wins 2014 Progressive Grocer Editor’s Pick Award 2Health News:Stanford-affiliated StartX Showcases Startups, New HQ, and Growth of Stanford-StartX Fund 2Health News:Stanford-affiliated StartX Showcases Startups, New HQ, and Growth of Stanford-StartX Fund 3Health News:Stanford-affiliated StartX Showcases Startups, New HQ, and Growth of Stanford-StartX Fund 4Health News:Stanford-affiliated StartX Showcases Startups, New HQ, and Growth of Stanford-StartX Fund 5Health News:Stanford-affiliated StartX Showcases Startups, New HQ, and Growth of Stanford-StartX Fund 6
... Veto Will Deprive Six Million American Children of Healthcare ... of,Child and Adolescent Psychiatry strongly urges Congress to override,President ... 976) act., The House passed the S-CHIP bill ... enough to override the President,s veto. The Senate passed ...
... Pam Brady,President of the California State PTA, ... federal legislation to expand the State,Children,s Health Insurance ... morning of legislation to expand the SCHIP,program is ... families,including approximately 800,000 in California, who need medical ...
... Oct. 3 Prominent cosmetic dentist Dr. William,Hoskyns has ... partner.,Dr. Hoskyns joins Dr. Debra Gray King and her ... Arizona where he had an international,reputation as the dentist ... reconstruction. Well known for his celebrity and high ...
... Medical,Technologies, Inc. (Nasdaq: VNUS ), a leading provider ... reflux disease, today,announced that it presented at the William ... ET on October 3, 2007, at the New York,Palace ... of the VNUS presentation webcast is available on the,corporate ...
... Effective in High Risk Angioplasty Patients, TORONTO, ... over the,past year about the safety and potential ... possible fatal blood clots, even years,after an angioplasty ... from Ontario,s Institute for Clinical Evaluative Sciences,(ICES) and ...
... 3 The American Health Information,Management Association ... assessment and training consultation services for the,Centers ... AHIMA,s signing of,a contract with the nation,s ... requires AHIMA to determine ICD-10,s,impact(s) on CMS; ...
Cached Medicine News:Health News:American Academy of Child and Adolescent Psychiatry Reacts to S-CHIP Veto 2Health News:Prominent Cosmetic Dentist Dr. William Hoskyns Joins Leading Atlanta Practice 2Health News:New Canadian study finds drug coated heart stents to be safe: 2Health News:New Canadian study finds drug coated heart stents to be safe: 3Health News:New Canadian study finds drug coated heart stents to be safe: 4Health News:AHIMA Signs Contract With CMS for ICD-10 Implementation Assessment and Training 2
... The Vitros ECi brings true ... to immunodiagnostic testing. Highly sensitive assays ... oncology and bone metabolism testing are ... under development. The Vitros ECi can ...
... is a flexible system that ... environments small hospitals, backup ... satellite locations. The Vitros 250 ... can be automated or placed ...
... an effort to improve on the ... toxicology, abused drugs, and immunosuppressants tests, ... which incorporates random access capabilities. Although ... undergone several important changes in the ...
The IMx system is an automated analyzer designed to perform microparticle enzyme immunoassay (MEIA), fluorescence polarization immunoassay (FPIA) and ion capture technologies....
Medicine Products: